Research

Globe and Mail Catastrophic Drug Coverage Series

Health Council of Canada Progress Report 2011: Health Care Renewal in Canada

Bendamustine for treatment of iNHL and MCL

Rituximab and Elderly Mantle Cell Patients

Bendamustine added to BC Drug Benefit List

New Treatment Option for Relapsed Indolent B-cell Non-Hodgkin Lymphoma

Report Card on Wait Times In Canada Released

New Program Launched For Safe Medication Use.

2011-2012 Report Card on Cancer in Canada

Ottawa Mayor proclaims Lymphoma Awareness Day